Dimerix Ltd (dxb) Logo

Dimerix Ltd (DXB)

___:___ · Healthcare
ASX Delayed
Cboe Live

What is live streaming pricing?

Stock prices will auto-update without reloading the page. How it works:

  • Flashing prices signify an increase (green) or decrease (red) from previous price. Otherwise, price is unchanged.
  • Expect a short delay while pricing data initially loads.
  • Note, prices only update during market hours (10am-4:13pm AEST).

More about Cboe Live pricing.

OK, got it
0.00
0.00
(0.00)
VOLUME
DIV YIELD
PE RATIO
1 YR RETURN
52 WEEK RANGE

DXB ASX Chart

Snapshot

Dimerix Limited (DXB) is a clinical-stage biopharmaceutical company developing innovative new therapies in areas with unmet medical needs for global markets. Dimerix is developing its proprietary product DMX-200, for Focal Segmental Glomerulosclerosis (FSGS), respiratory complications associated with COVID-19 and Diabetic Kidney Disease and is developing DMX-700 for Chronic Obstructive Pulmonary Disease (COPD). Receptor-HIT is licensed non-exclusively to Excellerate Bioscience, a UK-based pharmacological assay service provider with a worldwide reputation for excellence in the field of molecular and cellular pharmacology.

Share Price Activity (ASX)

Last (Price)
Change 0.00 (0.00)
Bid / Ask -
Volume
Volume (4w avg)
Turnover
Open
Day Range -
VWAP
Prev Close
Last Trade

Performance

1 Week
1 Month
2024 YTD
1 Year
vs Sector (1yr) +98.72%
vs ASX 200 (1yr) +91.94%

Size

Market Cap Question Mark Icon
Excludes mandatory escrowed shares and foreign shares.
ASX Rank 957 of 2,385
Sector Rank 73 of 223

Key Fundamentals

Shares Issued
Sector Healthcare
Similar Companies IMR / OCC / RCE
EPS -$0.042
DPS $0.00
Book Value Per Share $0.014

Broker Consensus

DXB is not covered by a major broker, or data from most recent compilation was omitted due to not meeting QA guidelines.

Announcements

Price Sensitive only

Corporate Overview

Corporate Details

Head Office Fitzroy VIC 3065
Website www.dimerix.com
Registry Automic Group
Auditor Stantons
Date Listed 4 Feb 1993

Upcoming Calendar (Forecasted)

Date Event
04/03/2024 Issued Shares
28/08/2024 Report (Prelim)
28/08/2024 Report (Annual)
24/02/2025 Report (Interim)

Former Company Names

  • Sun Biomedical Limited (SBN), 30/11/2015
  • Harrington Group Limited (HGR), 18/12/2007
  • Ausfor Limited (ASF), 09/05/1997
  • Pine Forests of Australia [Orange] Limited, 06/12/1988

Dividend History

DPS and Yield calculations use the Pay Date.

Ex-Date Amount Franking Gross Type Payable
No dividends paid.

See Upcoming Dividends for all ASX companies.

Directors & Management

Directors

Management

Director Transactions

DXB directors must report any change in shareholding to the ASX within 5 business days.

See Director Transactions for all ASX companies.

Date Director Type Amount Price Value Notes
01/12/23 Nina Webster Issued 2,052,956 $0.138 $282,675 Employee Share Ownership Plan
30/10/23 Nina Webster Expiry 6,351,975 $0.170 $1,079,835 Options expired
28/06/23 Sonia Poli Issued 11,334 $0.400 $4,533 Rights issue
28/06/23 Nina Webster Issued 34,167 $0.400 $13,666 Rights issue
05/06/23 Sonia Poli Issued 125,002 $0.068 $8,500 Rights issue
05/06/23 Sonia Poli Issued 125,000 $0.080 $10,000 Rights issue
05/06/23 Nina Webster Issued 187,500 $0.068 $12,750 Rights issue
05/06/23 Nina Webster Issued 187,500 $0.080 $15,000 Rights issue
05/10/21 Nina Webster Issued 25,000 $0.270 $6,750 Placement
05/10/21 Nina Webster Issued 50,000 $0.200 $10,000 Issue of securities
05/10/21 Sonia Poli Issued 167,202 $0.270 $45,144 Director remuneration
05/10/21 Sonia Poli Issued 37,500 $0.270 $10,125 Placement
05/10/21 Sonia Poli Issued 75,000 $0.200 $15,000 Issue of securities
05/10/21 Hugh Alsop Issued 167,202 $0.270 $45,144 Director remuneration
05/10/21 James Williams Issued 264,736 $0.270 $71,478 Director remuneration
05/10/21 James Williams Issued 62,500 $0.270 $16,875 Placement
05/10/21 James Williams Issued 125,000 $0.200 $25,000 Issue of securities
21/04/21 Sonia Poli Expiry 125,000 $0.260 $32,500 Options expired
21/04/21 Hugh Alsop Expiry 125,000 $0.260 $32,500 Options expired
21/04/21 James Williams Expiry 175,000 $0.260 $45,500 Options expired
27/11/18 Nina Webster Issued 6,351,975 $0.021 $130,427 Issue of options
07/09/18 Nina Webster Buy +45,000 $0.110 $4,950 On-market trade
18/07/18 David Franklyn Buy +13,798 $0.094 $1,297 Conversion of securities
18/07/18 James Williams Buy +121,016 $0.094 $11,376 Conversion of securities
18/07/18 James Williams Exercise 121,016 $0.094 $11,376 Conversion of securities
18/07/18 David Franklyn Exercise 13,798 $0.094 $1,297 Conversion of securities
25/05/18 David Franklyn Buy +200,000 $0.100 $20,000 On-market trade
24/05/18 James Williams Buy +50,000 $0.100 $5,000 On-market trade
25/01/18 David Franklyn Issued 82,786 $0.120 $9,934 Rights issue
25/01/18 James Williams Issued 416,669 $0.120 $50,000 Rights issue
17/11/17 Hugh Alsop Issued 125,000 $0.175 $21,875 Issue of options
17/11/17 Sonia Poli Issued 125,000 $0.175 $21,875 Issue of options
17/11/17 David Franklyn Issued 125,000 $0.175 $21,875 Issue of options
17/11/17 James Williams Issued 175,000 $0.175 $30,625 Issue of options
30/06/17 Sonia Poli Expiry 2,152,437 $0.010 $21,524 Options expired
28/02/17 Sonia Poli Buy +2,600,000 $0.008 $20,800 On-market trade
24/02/17 James Williams Buy +4,250,000 $0.007 $29,796 On-market trade
28/04/16 David Franklyn Exercise 275,954 $0.007 $1,932 Conversion of securities
28/04/16 David Franklyn Buy +275,954 $0.007 $1,932 Conversion of securities
28/04/16 James Williams Exercise 2,420,283 $0.007 $16,942 Conversion of securities
28/04/16 James Williams Buy +2,420,283 $0.007 $16,942 Conversion of securities
19/02/16 James Williams Exercise 2,419,383 $0.006 $14,516 Conversion of securities
19/02/16 James Williams Buy +2,419,383 $0.006 $14,516 Conversion of securities
19/02/16 David Franklyn Exercise 275,954 $0.006 $1,656 Conversion of securities
19/02/16 David Franklyn Buy +275,954 $0.006 $1,656 Conversion of securities
03/07/15 Anton Uvarov Buy +764,943 $0.011 $8,414 Issue of securities
03/07/15 Anton Uvarov Buy +2,549,810 $0.011 $28,048 Issue of securities
29/12/14 Anton Uvarov Buy +97,981 $0.007 $686 On-market trade
22/12/14 Anton Uvarov Buy +402,019 $0.007 $2,834 On-market trade
04/12/14 Anton Uvarov Buy +285,215 $0.008 $2,287 On-market trade
03/12/14 Anton Uvarov Buy +714,785 $0.008 $5,733 On-market trade

Director Interests

The current holdings of DXB directors.

Director Last Notice Direct Shares Indirect Shares Options Convertibles
Nina Webster 01/12/2023 0 282,500 2,299,623 N/A
Mark Diamond 01/12/2023 0 N/A N/A N/A
Sonia Poli 30/06/2023 330,000 N/A 341,038 N/A
Hugh Alsop 30/06/2023 N/A N/A 167,202 N/A
Clinton Snow 01/05/2023 0 N/A N/A N/A

Shareholder Info

Top 20 Shareholders

Data supplied by Morningstar and accurate on Aug 28, 2023.

It's not possible to publish a real-time Top 20 Shareholder list. Companies are not obliged to report this data (with the exception of Substantial Shareholders above 5%). If a company chooses to publish the data, it's usually once a year in their Annual Report.

All data is manually compiled so there might be a delay between the Annual Report being published and the data appearing on Market Index (<7 days for ASX 300 and up to 30 days for micro-caps).

Name Shares Capital
Mr Peter Fletcher Meurs 35,572,412 9.08%
Skiptan Pty Ltd <P&M Meurs Family A/C> 29,357,028 7.50%
Freedom Trader Pty Ltd 9,375,152 2.39%
Bavaria Bay Pty Ltd 7,316,992 1.87%
Yodambao Pty Ltd 6,362,603 1.62%
Mrs Melinda Jane Coates & Mr Andrew Joseph Coates 5,000,000 1.28%
Mrs Julie Maree Scott 4,425,000 1.13%
Mr Philip Robert Scott 4,425,000 1.13%
Mr Andrew Joseph Coates & Mrs Melinda Jane Coates 4,311,500 1.10%
Mr Richard Stanley De Ravin 4,200,000 1.07%
Tamer Yigit Property Group Pty Ltd 3,870,000 0.99%
Mr Taylor Nicholas Green 3,500,000 0.89%
Mr Anthony Mark Van Der Steeg 3,090,519 0.79%
Limnos 34 Pty Ltd 3,000,728 0.77%
Mrs Gwen Murray Pfleger 2,807,984 0.72%
Rubi Holdings Pty Ltd 2,500,000 0.64%
Coates Family Office Pty Ltd 2,300,000 0.59%
Toroha Pty Ltd 2,137,753 0.55%
Solequest Pty Ltd 2,000,000 0.51%
Moore Family Nominees Pty Ltd 2,000,000 0.51%
Citicorp Nominees Pty Limited 1,953,707 0.50%
Jampaso Pty Ltd 1,778,742 0.45%

Shareholder Distribution

As reported in the most recent Annual Report.

Holding Size 1 - 1,000 1,001 - 5,000 5,001 - 10,000 10,001 - 100,000 100,001+ Total
No. of Shareholders 253 1,380 900 1,911 547 4,991

Substantial Shareholders

A substantial shareholder is a person or entity that owns 5% or more of the voting shares in a company. Shares can be held through multiple entities, so the Substantial Shareholders list differs from the Top 20 Shareholders list.

Shareholding changes less than 1% do not require notification to the market. When all “Last Notice” dates are identical, it suggests that no (or minimal) change has occurred since the most recent Annual Report.

Note: If a substantial shareholder's stake drops below 5%, the "Shareholders Selling" field shows full ownership as sold and sets "New %" to zero, even if they continue to hold shares under the limit.

Name Last Notice Total Shares Shares Held (%)
Mr Peter Meurs 28/08/2023 64,929,440 16.58

Shareholders Buying

12 month transaction history compiled from ASX announcements.

Date Name Bought Previous % New %
05-06-23 Mr Peter Meurs 20,750,131 13.77 16.74

Shareholders Selling

12 month transaction history compiled from ASX announcements.

Date Name Sold Previous % New %
18-04-23 Merchant Funds Management Pty Ltd 17,925,000 5.59 --

Historical Data

Share Price History

Date Close Change %Chg Open High Low Volume Turnover

Historical Data

Year Closing Price Last Trade
2023 $0.062 30 June
2022 $0.120 30 June
2021 $0.195 30 June
2020 $0.350 30 June
2019 $0.085 28 June
2018 $0.095 29 June
2017 $0.010 28 June
2016 $0.007 28 June
DXB Historical Price Data (CSV)
Up to 20 years of EOD share price history

Important note:

All year-end and CSV data is "as traded on the day" and ignores corporate actions (e.g. share splits)

Market Index, ASX and Morningstar Logos

All data on this page is supplied by the ASX, Morningstar and Market Index. Read the disclaimer.